• helpDesk@lucintel.com
  • |
  • Llamar a Lucintel +1 972 636 5056
  • |
  • Acceso
  • |
  • Registro
  • |
  • Buscar
  • |
'
...

The Impact of COVID-19 is included in Biomarker Market.

Buy it today to get an advantage. Request the impact of COVID-19 on your product or industry


The future of the global biomarker market looks promising with opportunities in diagnostic development, drug discovery & development, and disease risk applications. The global biomarker market is expected to grow with a CAGR of 11%-13% from 2020 to 2025. The major drivers for this market are increasing applications of biomarkers in diagnostics, increasing research and development activities in pharma and biotech companies, and increasing contract research organizations.
 

 
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global biomarker market report, please download the report brochure.
 
The study includes trends and forecast for the global biomarker market by product, type, disease indication, application, and region as follows:
 
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Consumables
  • Servicios
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Safety
  • Efficacy
  • Validation
By Disease Indication [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Cancer
  • Cardiovascular Disorders
By Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Diagnostics Development
  • Drug Discovery and Development
  • Disease Risk
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • América del norte
  • Estados Unidos
  • Canadá 
  • México
  • Europa
  • Reino Unido
  • Alemania
  • Francia
  • Asia Pacífico
  • Porcelana
  • India
  • Japón
  • The Rest of the World 
  • Brasil
Some of the biomarker companies profiled in this report include Qiagen, Perkinelmer, Merck Millipore, Bio-Rad Laboratories, Enzo Biochem, EKF Diagnostics, Meso Scale Diagnostics, Biosims Technologies, Cisbio Bioassays, and Signosis.
 
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to rising usage of reagent kits and assays for biomarker testing.
 
Within this market, cancer will remain the largest segment by disease indication over the forecast period due to increasing adoption of accurate and rapid diagnostic tools and rising demand for personalized medicines. 
 
North America will remain the largest region over the forecast period due to increasing prevalance of diseases, favorable government initiatives, and presence of major market players. These factors will contribute to biomarker-based drug discovery and development in the region. 
 
 
Features of the Global Biomarker Market
 
  • Market Size Estimates: Global biomarker market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global biomarker market size by various segments, such as product, type, disease indication, and application, in terms of value.
  • Regional Analysis: Global biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products, types, disease indications, applications, and regions for the global biomarker market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global biomarker market.
  • Análisis de la intensidad competitiva de la industria basada en el modelo de cinco fuerzas de Porter.
 
 
 
This report answers following key questions

  Q.1 What are some of the most promising potential, high-growth opportunities for the global biomarker market by product (consumables and service), type (safety, efficacy, and validation), disease indication (cancer and cardiovascular disorders), application (diagnostics development, drug discovery & development, and disease risk), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global biomarker market?
Q.5 What are the business risks and threats to the global biomarker market?
Q.6 What are the emerging trends in this biomarker market and the reasons behind them?
Q.7 What are some changing demands of customers in this biomarker market?
Q.8 What are the new developments in this biomarker market? Which companies are leading these developments?
Q.9 Who are the major players in this biomarker market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this biomarker market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global biomarker market?

 
 
Report Scope

Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)
2014-2019
Forecast Period 2020-2025
Páginas More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Consumables and Service), Type (Safety, Efficacy, and Validation), Disease Indication (Cancer and Cardiovascular Disorders), and Application (Diagnostics Development, Drug Discovery and Development, and Disease Risk)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Customization 10% Customization without Any Additional Cost

Tabla de contenido
 
1. Executive Summary
 
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biomarker Market Trends and Forecast
3.3: Global Biomarker Market by Product
3.3.1: Consumables
3.3.2: Services
3.4: Global Biomarker Market by Type
3.4.1: Safety 
3.4.2: Efficacy
3.4.3: Validation
3.5: Global Biomarker Market by Disease Indication
3.5.1: Cancer
3.5.2: Cardiovascular Disorders
3.6: Global Biomarker Market by Application
3.6.1: Diagnostics Development
3.6.2: Drug Discovery and Development
3.6.3: Disease Risk
 
4. Market Trends and Forecast Analysis by Region
4.1: Global Biomarker Market by Region
4.2: North American Biomarker Market
4.2.1: Market by Product: Consumables and Service
4.2.2: Market by Type: Safety, Efficacy, and Validation 
4.2.3: Market by Disease Indication: Cancer and Cardiovascular Disorders 
4.2.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk 
4.2.5: The United States Biomarker Market
4.2.6: The Canadian Biomarker Market
4.2.7: The Mexican Biomarker Market
4.3: European Biomarker Market
4.3.1: Market by Product: Consumables and Service 
4.3.2: Market by Type: Safety, Efficacy, and Validation 
4.3.3: Market by Disease Indication: Cancer and Cardiovascular Disorders 
4.3.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk 
4.3.5: The Biomarker Market of the United Kingdom
4.3.6: The German Biomarker Market
4.3.7: The French Biomarker Market
4.4: APAC Biomarker Market
4.4.1: Market by Product: Consumables and Service 
4.4.2: Market by Type: Safety, Efficacy, and Validation 
4.4.3: Market by Disease Indication: Cancer and Cardiovascular Disorders 
4.4.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk 
4.4.5: The Chinese Biomarker Market
4.4.6: The Indian Biomarker Market
4.4.7: The Japanese Biomarker Market
4.5: ROW Biomarker Market
4.5.1: Market by Product: Consumables and Service 
4.5.2: Market by Type: Safety, Efficacy, and Validation 
4.5.3: Market by Disease Indication: Cancer and Cardiovascular Disorders 
4.5.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk 
4.5.5: Brazilian Biomarker Market
 
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
 
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
 
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biomarker Market by Product 
7.1.2: Growth Opportunities for the Global Biomarker Market by Type
7.1.3: Growth Opportunities for the Global Biomarker Market by Disease Indication
7.1.4: Growth Opportunities for the Global Biomarker Market by Application
7.1.5: Growth Opportunities for the Global Biomarker Market by Region
7.2: Emerging Trends in the Global Biomarker Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biomarker Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Market
7.3.4: Certification and Licensing
 
8. Company Profiles of Leading Players
8.1: Qiagen N.V. 
8.2: Perkinelmer, Inc. 
8.3: Merck Millipore
8.4: Bio-Rad Laboratories, Inc.
8.5: Enzo Biochem, Inc. 
8.6: EKF Diagnostics Holdings, Inc. 
8.7: Meso Scale Diagnostics, LLC. 
8.8: Biosims Technologies Sas
8.9: Cisbio Bioassays
8.10: Signosis, Inc.
.

Comprar un informe completo o por capítulo de la siguiente manera

Oferta por tiempo limitado

Precio por tipo de licencia:
[-] ocultar detalles del capítulo
[Número de capítulo] [Nombre del capítulo] [Capítulo Número de páginas] [Precio del capítulo]
Nombre del título/capítulo Páginas Precio
Full Report: Biomarker Market: Trends, Forecast and Competitive Analysis Informe completo $ 2,990
150 - page report
Lucintel ha estado en el negocio de la consultoría de investigación y gestión de mercado desde 2000 y ha publicado más de 1000 informes de inteligencia de mercado en varios mercados / aplicaciones y atendió a más de 1,000 clientes en todo el mundo. Este estudio es una culminación de cuatro meses de esfuerzo a tiempo completo realizado por el equipo analista de Lucintel. Los analistas utilizaron las siguientes fuentes para la creación y finalización de este valioso informe:
  • Entrevistas en profundidad de los principales actores en este mercado
  • Investigación secundaria detallada de los estados financieros de los competidores y datos publicados 
  • Extensas búsquedas de obras publicadas, mercado e información de bases de datos relacionadas con noticias de la industria, comunicados de prensa de la empresa e intenciones de clientes
  • Una compilación de las experiencias, juicios e ideas de los profesionales de Lucintel, que han analizado y rastreado este mercado a lo largo de los años.
Se realizan una extensa investigación y entrevistas en la cadena de suministro de este mercado para estimar la cuota de mercado, el tamaño del mercado, las tendencias, los impulsores, los desafíos y las previsiones. A continuación se muestra un breve resumen de las entrevistas principales que se llevaron a cabo por la función de trabajo para este informe.
 
Por lo tanto, Lucintel compila grandes cantidades de datos de numerosas fuentes, valida la integridad de esos datos y realiza un análisis exhaustivo. Lucintel luego organiza los datos, sus hallazgos y las ideas sobre un informe conciso diseñado para respaldar el proceso estratégico de toma de decisiones. La siguiente figura es una representación gráfica del proceso de investigación de Lucintel. 
 

Please sign in below to get report brochure - Biomarker Market.

En Lucintel, respetamos su privacidad y mantenemos la confidencialidad de la información / datos proporcionados por usted
(Ingrese su correo electrónico corporativo. * Estos campos son obligatorios)

Séguenos